MW MARKET WATCH
CDIO
Cardio Diagnostics Holdings, Inc. — NASDAQ • Healthcare / Biotech
$4.74 -0.12%
$8.6M
Market Cap
11.9M
Volume
$4.97
EMA 200
8.5%
Short / Float
$6.3M
Cash
75.3
RSI (OB)
AI PRECISION MEDICINE INDIA EXPANSION EPIGENETIC TECH

Quick Verdict

C+
Speculative / Event-Driven

CDIO is a high-risk micro-cap biotech leveraging epigenetics for CVD detection. Recent pivot to global commercialization with a massive India partnership. Extreme volatility (+300% from lows). Revenue is currently negligible, requiring close watch on burn rate.

Business Activity

Epi+Gen CHD
Flagship 3-year CHD risk assessment test.
PrecisionCHD
Integrated genetic-epigenetic clinical blood test.

Financials

TRADE IDEA: EPIGENETIC BOUNCE

ENTRY
$4.20 - $4.50
STOP
$3.80
TP1
$5.80
TP2
$8.50
R/R
1:3.2

Social Radar

VerdictTrade IdeaSocial Radar